Prescribing Trends of Oral Anticoagulants in US Patients With Cirrhosis and Nonvalvular Atrial Fibrillation

BACKGROUND: Many patients with cirrhosis have concurrent nonvalvular atrial fibrillation (NVAF). Data are lacking regarding recent oral anticoagulant (OAC) usage trends among US patients with cirrhosis and NVAF. METHODS AND RESULTS: Using MarketScan claims data (2012–2019), we identified patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Simon, Tracey G., Schneeweiss, Sebastian, Singer, Daniel E., Sreedhara, Sushama Kattinakere, Lin, Kueiyu Joshua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973619/
https://www.ncbi.nlm.nih.gov/pubmed/36625307
http://dx.doi.org/10.1161/JAHA.122.026863

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973619/
https://www.ncbi.nlm.nih.gov/pubmed/36625307
http://dx.doi.org/10.1161/JAHA.122.026863

Ejemplares similares